MarketCapExport financials
CorMedix (CRMD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
CorMedix Income Statement 2025-2006 | CRMD
Brief overview of profit and loss at CorMedix
The figures are compared over a five-year interval. Revenue reported by CorMedix was 239 thousand dollars at the beginning of the period and 312 million dollars at the end. The total change was +130196.2%, with a CAGR of approximately 319.7%. Revenue growth reflects a pronounced phase of business expansion.
At the gross-profit level, the result moved from 34.4 thousand dollars to 276 million dollars, a change of +801842.7%. Revenue outpaced cost of revenue, allowing more sales to flow into gross profit. Gross margin moved from 14.4% to 88.5%. The margin shift points to a more favorable sales-and-cost structure.
EBITDA changed from −$27.1 million to $151 million (+656.7%). Changes in revenue did not translate into comparable EBITDA performance. Comparing the endpoints gives EBITDA margins of −11324.9% and 48.4%. The business generated more EBITDA from each unit of revenue.
Net income moved from −$22 million at the start to $163 million at the end. The business moved out of a loss and ended the period with a profit.
The five-year change in capitalization reached −99.8%: from $250 million to $456 thousand. Capitalization lags the underlying business improvement.
Financial takeaway
Positive developments coexist with areas of weakness. The positive side is supported by an improving EBITDA margin, improving net profitability and better sales economics. Caution is warranted because of a weaker market valuation. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement CorMedix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
456 K | 373 K | 174 M | 137 M | 159 M | 250 M | 162 M | 167 M | 25.9 M | 64.2 M | 55.8 M | 66.5 M | 32.6 M | 11.1 M | 4.34 M | 155 M | - | - | - | - |
Shares |
72 K | 58.9 K | 50.9 M | 40.3 M | 37.7 M | 28.6 M | 24.2 M | 17.8 M | 11 M | 7.59 M | 6.27 M | 4.29 M | 2.76 M | 2.28 M | 2.28 M | 11.4 M | - | - | - | - |
Historical Prices |
6.33 | 6.33 | 3.42 | 3.4 | 4.23 | 8.75 | 6.35 | 10.1 | 2.35 | 8.3 | 8.9 | 15.5 | 11.3 | 4.65 | 1.7 | 13.6 | - | - | - | - |
Net Income |
163 M | -17.9 M | -46.3 M | -29.7 M | -28.2 M | -22 M | -16.4 M | -26.8 M | -33 M | -24.6 M | -18.2 M | -20.5 M | -9.13 M | -3.43 M | -6.71 M | -10.9 M | -8.12 M | -9 M | -7.24 M | -975 K |
Revenue |
312 M | 43.5 M | - | 65.4 K | 191 K | 239 K | 283 K | 430 K | 329 K | 224 K | 210 K | 189 K | 2 K | - | - | - | - | - | - | - |
Cost of Revenue |
22.1 M | 3.03 M | - | 3.73 K | 149 K | 205 K | 373 K | 397 K | 115 K | 367 K | -319 K | -446 K | -202 K | - | - | - | - | - | - | - |
Gross Profit |
276 M | 40.3 M | - | 61.7 K | 42 K | 34.4 K | -90 K | 33 K | 214 K | -143 K | -109 K | -257 K | -200 K | - | - | - | - | - | - | - |
Operating Income |
150 M | -22.4 M | -49 M | -30.6 M | -29.4 M | -27.2 M | -21 M | -26.9 M | -32.9 M | -24.8 M | -16.7 M | -8.9 M | -4.92 M | -3 M | -7.21 M | -8.51 M | - | - | - | - |
Interest Expense |
- | 1.4 M | 34.3 K | 26.5 K | 15.9 K | 33.2 K | 787 K | 1.87 K | 5.62 K | 1.31 K | 3.96 K | 2.09 K | 1.44 M | 383 K | - | 3.09 M | - | - | - | - |
EBITDA |
151 M | -22.2 M | -48.9 M | -30.5 M | -29.4 M | -27.1 M | -20.9 M | -26.8 M | -32.9 M | -24.7 M | -16.6 M | -8.89 M | -4.91 M | -3.04 M | -7.23 M | -8.49 M | - | - | - | - |
Operating Expenses |
126 M | 62.6 M | 49 M | 30.7 M | 29.5 M | 27.3 M | 20.9 M | 26.9 M | 33.1 M | 24.6 M | 16.5 M | 8.65 M | 4.72 M | 3.04 M | 7.25 M | 8.51 M | - | - | - | - |
General and Administrative Expenses |
68.2 M | 30 M | 17.7 M | 20 M | 16.3 M | -13.9 M | 9.87 M | 8.07 M | 8.65 M | 8.88 M | 10.3 M | 7.33 M | 3.49 M | 1.86 M | 3.15 M | 3.01 M | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement CorMedix
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
67.9 M | 79.5 M | - | 75.9 M | 67.9 M | 65.2 M | 64.4 M | 58.8 M | 57.6 M | 57.5 M | 54.9 M | 56.6 M | 45.4 M | 44.1 M | 42.8 M | 41.2 M | 39.8 M | 38.2 M | 38.1 M | 38.1 M | 38.1 M | 36.3 M | 33.6 M | 29.6 M | 26.1 M | 26.1 M | 25.7 M | 24 M | 23.8 M | 23.1 M | 21.8 M | 18.8 M | 16.5 M | 15.1 M | 71.4 M | 60.3 M | 52.6 M | 40.6 M | 40.4 K | 39.1 M | 36.4 M | 36 M | 35.4 K | 34.6 K | 31.6 M | 23.9 K | 22.5 M | 22.1 M | 22 M | 19.3 M | 16.6 M | 14.4 M | 13 M | 11.6 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M |
Net Income |
19.8 M | 38.6 M | - | 109 M | 19.8 M | 20.6 M | - | -2.78 M | -14.2 M | -14.5 M | - | -9.74 M | -11.3 M | -10.6 M | - | -6.85 M | -7.6 M | -7.03 M | - | -8.57 M | -4.63 M | -7.22 M | - | -6.6 M | -3.78 M | -5.56 M | - | -5.26 M | -696 K | -5.17 M | - | -10.2 M | -8.56 M | -10.2 M | - | -9.96 M | -5.15 M | -7.6 M | -6.4 K | -9.13 M | -4.89 M | -4.12 M | -3.87 K | -4.69 K | -4.14 K | -5.5 K | - | -5.04 M | 3.51 M | -16.7 M | - | -2.5 M | -1.95 M | -1.25 M | - | -1.02 M | -613 K | -899 K | - | -2.6 M | -2.48 M | -1.98 M |
Revenue |
39.7 M | 127 M | - | 104 M | 39.7 M | 39.1 M | - | 11.5 M | 806 K | - | - | - | - | - | - | 6.82 K | 21.3 K | 7.64 K | - | 38.1 K | 8.19 K | 88.3 K | - | 93 K | 16.4 K | 74.1 K | - | 59.5 K | 35.3 K | 164 K | - | 373 K | 7.55 K | 23.2 K | - | 61.1 K | 136 K | 39.6 K | 121 | 44.5 K | 16.5 K | 41.4 K | 23 | 36 | 120 | 31 | - | 52.4 K | 39.7 K | 12.2 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.81 M | 12 M | - | 7.57 M | 1.86 M | 1.6 M | - | 635 K | 510 K | 819 K | - | - | - | - | - | 1.47 K | 332 | 1.53 K | - | 25.2 K | 14.4 K | 61.3 K | - | 79.9 K | 19.2 K | 48.5 K | - | 79 K | 21.1 K | 227 K | - | 312 K | 33.7 K | 28.6 K | - | 66.7 K | 18.1 K | 93.6 K | -85 | 43.9 K | 187 K | 50.2 K | -164 | -35 | -102 | -17 | - | -36.7 K | -54.5 K | -81 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
37.9 M | 105 M | - | 93.1 M | 37.9 M | 37.5 M | - | 10.8 M | 296 K | -819 K | - | - | - | - | - | 5.35 K | 20.9 K | 6.11 K | - | 12.9 K | -6.24 K | 26.9 K | - | 13.1 K | -2.74 K | 25.5 K | - | -19.5 K | 14.1 K | -63.3 K | - | 60.1 K | -26.1 K | -5.36 K | - | -5.58 K | 118 K | -54 K | 36 | 529 | -171 K | -8.8 K | -141 | 1 | 18 | 14 | - | 15.8 K | -14.8 K | -68.8 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
19.5 M | 63.7 M | - | 51.3 M | 19.5 M | 20.1 M | - | -3.29 M | -15.3 M | -16.7 M | - | -10.5 M | -11.8 M | -11 M | - | -6.96 M | -8.24 M | -7.03 M | - | -8.56 M | -5.88 M | -7.21 M | - | -6.6 M | -8.92 M | -5.61 M | - | -5.17 M | -5.54 M | -4.92 M | - | -10.2 M | -8.57 M | -10.2 M | - | -8.01 M | -7.02 M | -7.62 M | -6.43 K | -9.16 M | -4.91 M | -4.15 M | -3.89 K | -4.71 K | -4.14 K | -3.91 K | - | -1.86 M | -1.89 M | -8.9 M | - | -1.26 M | -1.29 M | -807 K | - | -991 K | -614 K | -900 K | - | -2.6 M | -2.48 M | -2.01 M |
Interest Expense |
- | - | - | - | - | - | - | - | 6.56 K | - | - | 13.1 K | 5.85 K | 8.78 K | - | 8.78 K | 3.58 K | 5.38 K | - | 5.38 K | 5.18 K | 5.18 K | - | 7.8 K | 13.8 K | 6.28 K | - | 172 K | 307 K | 302 K | - | - | - | 1.87 K | - | 2.81 K | - | - | - | - | 41 | 992 | - | 1.61 K | 3.69 K | 859 | - | 553 | 513 | 465 | - | 312 K | 661 K | 440 K | - | 26.1 K | - | - | - | - | - | 29.8 K |
EBITDA |
19.5 M | 74.2 M | - | 54.9 M | - | 20.2 M | - | - | - | -16.7 M | - | - | - | -11 M | - | -6.9 M | -8.2 M | -7.01 M | - | -8.52 M | -5.86 M | -7.2 M | - | -6.56 M | -8.88 M | -5.59 M | - | -5.11 M | -5.5 M | -4.9 M | - | -10.2 M | -8.53 M | -10.2 M | - | -7.99 M | -7 M | -7.61 M | -6.43 K | -9.14 M | -4.9 M | -4.14 M | -3.89 K | 6.38 K | 2.98 K | -756 | - | -1.85 M | -1.89 M | -8.9 M | - | -1.25 M | -1.29 M | -806 K | - | -986 K | -610 K | -898 K | - | -2.59 M | -2.47 M | -2.01 M |
Operating Expenses |
18.3 M | 41.5 M | - | 41.7 M | 18.3 M | 17.4 M | - | 14.1 M | 15.6 M | 15.9 M | - | 10.5 M | 11.8 M | 11 M | - | 6.97 M | 8.26 M | 7.04 M | - | 8.58 M | 5.88 M | 7.24 M | - | 6.62 M | 8.92 M | 5.64 M | - | 5.15 M | 5.55 M | 4.86 M | - | 10.3 M | 8.55 M | 10.2 M | - | 8.01 M | 7.14 M | 7.56 M | - | 9.16 M | 4.74 M | 4.14 M | - | 4.71 M | 4.15 M | 3.93 M | - | 1.88 M | 1.87 M | 2.87 M | - | 1.26 M | 1.29 M | 807 K | - | 991 K | 614 K | 900 K | - | 2.6 M | 2.48 M | 2.01 M |
General and Administrative Expenses |
9.5 M | 21.7 M | - | 25.5 M | 9.5 M | 9.69 M | - | 6.58 M | 7.56 M | 8.71 M | - | 3.74 M | 3.75 M | 7.61 M | - | 4.63 M | 5.05 M | 4.75 M | - | 3.84 M | 3.36 M | 4.6 M | - | 3.69 M | 3.23 M | 3.17 M | - | 2.63 M | 2.57 M | 1.98 M | - | 2.01 M | 1.95 M | 1.9 M | - | 1.99 M | 2.05 M | 2.64 M | 2.43 K | 2.32 K | 1.97 K | 2.16 K | 2.27 K | 2.95 K | 2.36 K | 2.69 K | - | 1.59 M | 1.7 M | 2.51 M | - | 505 K | 909 K | 552 K | - | 747 K | 377 K | 536 K | - | 877 K | 898 K | 834 K |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company CorMedix (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Russia
USA
Canada
Niderland
Israel
Spain
Germany
Australia
Britain
